172 related articles for article (PubMed ID: 11968345)
1. [Treatment of chronic hepatitis C in patients not responding to interferon].
Moreno Monteagudo JA; García Buey L; Moreno Otero R
Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():51-6. PubMed ID: 11968345
[No Abstract] [Full Text] [Related]
2. Re: Khalili et al.--chronic Hepatitis C treatment in interferon nonresponders.
Glaser D
Am J Gastroenterol; 2000 Nov; 95(11):3315-6. PubMed ID: 11095370
[No Abstract] [Full Text] [Related]
3. [Treatment of chronic hepatitis C in patients without previous treatment].
Dehesa Violante M
Rev Gastroenterol Mex; 2002 Oct; 67 Suppl 2():S42-4. PubMed ID: 12712852
[TBL] [Abstract][Full Text] [Related]
4. Role of amantadine and other adjuvant therapies in the treatment of hepatitis C.
Brillanti S
Semin Liver Dis; 2004; 24 Suppl 2():89-95. PubMed ID: 15346251
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of chronic hepatitis C. Combined treatment in naive patients].
Forns Bernhardt X
Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():43-6. PubMed ID: 11968343
[No Abstract] [Full Text] [Related]
6. Treatment outcome of chronic hepatitis C in sickle cell disease and thalassemic patients with interferon and ribavirin.
Alavian SM; Tabatabaei SV
Eur J Gastroenterol Hepatol; 2010 Jan; 22(1):123-4. PubMed ID: 19959942
[No Abstract] [Full Text] [Related]
7. [Perspectives in hepatology in the next 2-3 years: what will be clinically relevant? Viral hepatitis].
Friedrich-Rust M; Forestier N; Zeuzem S
Dtsch Med Wochenschr; 2005 Dec; 130 Suppl 5():S229-30. PubMed ID: 16435720
[No Abstract] [Full Text] [Related]
8. Current treatment for chronic hepatitis C.
Davis GL
Rev Gastroenterol Disord; 2001; 1(2):59-72. PubMed ID: 12120176
[TBL] [Abstract][Full Text] [Related]
9. High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C.
Bressler BL; Guindi M; Tomlinson G; Heathcote J
Hepatology; 2003 Sep; 38(3):639-44. PubMed ID: 12939590
[TBL] [Abstract][Full Text] [Related]
10. [Similar poor response in genotype 4 chronic Hepatitis C treatment with interferon and ribavirin compared with genotype 1 treatment].
Pérez Mota A; Graus J; García Flores MA; Blanco M; Pérez-Muñoz C; Villalgordo C; Rodero R
Rev Esp Enferm Dig; 2003 Mar; 95(3):238-9. PubMed ID: 12760714
[No Abstract] [Full Text] [Related]
11. Combination therapy with ribavirin and amantadine in renal transplant patients with chronic hepatitis C virus infection is not superior to ribavirin alone.
Calanca LN; Fehr T; Jochum W; Fischer-Vetter J; Müllhaupt B; Wüthrich RP; Ambühl PM
J Clin Virol; 2007 May; 39(1):54-8. PubMed ID: 17409018
[TBL] [Abstract][Full Text] [Related]
12. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C, depressive symptoms, viral load, and therapy: interactions and reactions.
Douglas SD
Brain Behav Immun; 2005 Jan; 19(1):20-2. PubMed ID: 15581734
[No Abstract] [Full Text] [Related]
14. Non-interferon-based therapy: an option for amelioration of necro-inflammation in hepatitis C patients who cannot afford interferon therapy.
El-Zayadi AR; Attia M; Badran HM; El-Tawil A; Zalata K; Barakat E; Selim O; El-Nakeeb A; Saied A
Liver Int; 2005 Aug; 25(4):746-51. PubMed ID: 15998425
[TBL] [Abstract][Full Text] [Related]
15. [Chronic hepatitis C: what to do if the first treatment failed?].
Asselah T
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B50-9. PubMed ID: 12180309
[No Abstract] [Full Text] [Related]
16. [Hepatitis C treatment with amantadine-HCL in non-responders to alpha-interferon].
Smith JP
Arq Gastroenterol; 1999; 36(2):61-2. PubMed ID: 10511882
[No Abstract] [Full Text] [Related]
17. [Chronic hepatitis C. A new chance with Consensus Interferon for patients with handicaps].
MMW Fortschr Med; 2002 Nov; 144(45):56-7. PubMed ID: 12534066
[No Abstract] [Full Text] [Related]
18. Consensus interferon and ribavirin for patients with chronic hepatitis C and failure of previous interferon-alpha therapy.
Böcher WO; Schuchmann M; Link R; Hillenbrand H; Rahman F; Sprinzl M; Mudter J; Löhr HF; Galle PR
Liver Int; 2006 Apr; 26(3):319-25. PubMed ID: 16584394
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of hepatitis C: therapeutic management].
Bourliere M
Gastroenterol Clin Biol; 2008 May; 32(5 Pt 2):S166-71. PubMed ID: 18482813
[No Abstract] [Full Text] [Related]
20. Treatment of chronic hepatitis C in patients with renal disease.
Gane E
Med J Malaysia; 2005 Jul; 60 Suppl B():72-6. PubMed ID: 16108179
[No Abstract] [Full Text] [Related]
[Next] [New Search]
